No Benefit from Chronic Lithium Dosing in a Sibling-Matched, Gender Balanced, Investigator-Blinded Trial Using a Standard Mouse Model of Familial ALS

Alan Gill, Joshua Kidd, Fernando Vieira et al. · 2009

Read No Benefit from Chronic Lithium Dosing in a Sibling-Matched, Gender Balanced, Investigator-Blinded Trial Using a Standard Mouse Model of Familial ALS by Alan Gill, Joshua Kidd, Fernando Vieira et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0006489.txt.

Description

Alan Gill, Joshua Kidd, Fernando Vieira, and colleagues reported a negative drug trial in PLOS ONE in 2009. In animal models of human disease, a positive control therapy matters. If a treatment works in both the model and the human disease, it validates the model. Lithium was a candidate for such a test in a sibling-matched, gender-balanced, investigator-blinded trial.

Their title states the result plainly: no benefit from chronic lithium dosing in the trial. Negative results are vital, even when disappointing. They stop other teams from wasting effort on a dead end. They also question how well the animal model matches the human condition it was meant to mirror.

Catalog record

CREATORAlan Gill, Joshua Kidd, Fernando Vieira et al.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE37 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0006489

Browse the full library · About the Tower of Babel